Tag: #lifesciences

Moderna is advancing messenger RNA (mRNA) science to create a new class of mRNA medicines designed to direct the patient’s own cells to produce proteins that have a therapeutic or preventive benefit. Developing therapeutics and vaccines for a variety of diseases challenges process development and operations to establish agile and flexible manufacturing, capable of executing […]

Life science industries are transitioning from wet lab environments to digital labs. Digital labs decrease the “time to science” and de-risk R&D portfolios. Customers see computational methods as a way to increase the performance, throughput, and effectiveness of laboratory operations. This presents opportunities around long-standing challenges with experiment reproducibility and the ability to address lab […]